Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
- Autores
- Camprubí, Daniel; Almuedo Riera, Alex; Martí Soler, Helena; Soriano, Alex; Hurtado, Juan Carlos; Subirà, Carme; Grau Pujol, Berta; Krolewiecki, Alejandro Javier; Muñoz, José
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2.
Fil: Camprubí, Daniel. Universidad de Barcelona; España
Fil: Almuedo Riera, Alex. Universidad de Barcelona; España
Fil: Martí Soler, Helena. Universidad de Barcelona; España
Fil: Soriano, Alex. Universidad de Barcelona; España
Fil: Hurtado, Juan Carlos. Universidad de Barcelona; España
Fil: Subirà, Carme. Universidad de Barcelona; España
Fil: Grau Pujol, Berta. Universidad de Barcelona; España
Fil: Krolewiecki, Alejandro Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta; Argentina. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina
Fil: Muñoz, José. Universidad de Barcelona; España - Materia
-
COVID-19
SARS-COV-2
IVERMECTIN - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/160651
Ver los metadatos del registro completo
id |
CONICETDig_abaf9d9f14205b3b2dfe9ec96e045132 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/160651 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patientsCamprubí, DanielAlmuedo Riera, AlexMartí Soler, HelenaSoriano, AlexHurtado, Juan CarlosSubirà, CarmeGrau Pujol, BertaKrolewiecki, Alejandro JavierMuñoz, JoséCOVID-19SARS-COV-2IVERMECTINhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2.Fil: Camprubí, Daniel. Universidad de Barcelona; EspañaFil: Almuedo Riera, Alex. Universidad de Barcelona; EspañaFil: Martí Soler, Helena. Universidad de Barcelona; EspañaFil: Soriano, Alex. Universidad de Barcelona; EspañaFil: Hurtado, Juan Carlos. Universidad de Barcelona; EspañaFil: Subirà, Carme. Universidad de Barcelona; EspañaFil: Grau Pujol, Berta. Universidad de Barcelona; EspañaFil: Krolewiecki, Alejandro Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta; Argentina. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; ArgentinaFil: Muñoz, José. Universidad de Barcelona; EspañaPublic Library of Science2020-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/160651Camprubí, Daniel; Almuedo Riera, Alex; Martí Soler, Helena; Soriano, Alex; Hurtado, Juan Carlos; et al.; Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients; Public Library of Science; Plos One; 15; 11; 11-2020; 1-61932-6203CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242184info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0242184info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:38:32Zoai:ri.conicet.gov.ar:11336/160651instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:38:32.504CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients |
title |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients |
spellingShingle |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients Camprubí, Daniel COVID-19 SARS-COV-2 IVERMECTIN |
title_short |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients |
title_full |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients |
title_fullStr |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients |
title_full_unstemmed |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients |
title_sort |
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients |
dc.creator.none.fl_str_mv |
Camprubí, Daniel Almuedo Riera, Alex Martí Soler, Helena Soriano, Alex Hurtado, Juan Carlos Subirà, Carme Grau Pujol, Berta Krolewiecki, Alejandro Javier Muñoz, José |
author |
Camprubí, Daniel |
author_facet |
Camprubí, Daniel Almuedo Riera, Alex Martí Soler, Helena Soriano, Alex Hurtado, Juan Carlos Subirà, Carme Grau Pujol, Berta Krolewiecki, Alejandro Javier Muñoz, José |
author_role |
author |
author2 |
Almuedo Riera, Alex Martí Soler, Helena Soriano, Alex Hurtado, Juan Carlos Subirà, Carme Grau Pujol, Berta Krolewiecki, Alejandro Javier Muñoz, José |
author2_role |
author author author author author author author author |
dc.subject.none.fl_str_mv |
COVID-19 SARS-COV-2 IVERMECTIN |
topic |
COVID-19 SARS-COV-2 IVERMECTIN |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2. Fil: Camprubí, Daniel. Universidad de Barcelona; España Fil: Almuedo Riera, Alex. Universidad de Barcelona; España Fil: Martí Soler, Helena. Universidad de Barcelona; España Fil: Soriano, Alex. Universidad de Barcelona; España Fil: Hurtado, Juan Carlos. Universidad de Barcelona; España Fil: Subirà, Carme. Universidad de Barcelona; España Fil: Grau Pujol, Berta. Universidad de Barcelona; España Fil: Krolewiecki, Alejandro Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta; Argentina. Universidad Nacional de Salta. Sede Regional Orán. Instituto de Investigación de Enfermedades Tropicales; Argentina Fil: Muñoz, José. Universidad de Barcelona; España |
description |
Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/160651 Camprubí, Daniel; Almuedo Riera, Alex; Martí Soler, Helena; Soriano, Alex; Hurtado, Juan Carlos; et al.; Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients; Public Library of Science; Plos One; 15; 11; 11-2020; 1-6 1932-6203 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/160651 |
identifier_str_mv |
Camprubí, Daniel; Almuedo Riera, Alex; Martí Soler, Helena; Soriano, Alex; Hurtado, Juan Carlos; et al.; Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients; Public Library of Science; Plos One; 15; 11; 11-2020; 1-6 1932-6203 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242184 info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0242184 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Public Library of Science |
publisher.none.fl_str_mv |
Public Library of Science |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613218246328320 |
score |
13.070432 |